The FDA has approved Kisqali (ribociclib) in adults with HR-positive, HER2-negative stage II and III early breast cancer.

In a recent study, one dose of modified vaccinia Ankara-Bavarian Nordic vaccine had estimated vaccine effectiveness of 58%.

A new single-dose autoinjector presentation of Adbry ® (tralokinumab-ldrm) is now available for use in the treatment of moderate to severe atopic dermatitis not adequately controlled with topical ...

Eversense 365 is a fully-implantable CGM with a 365-day sensor, making it the first 1-year CGM option for diabetes management.

HealthDay News — Most nicotine brand Instagram posts do not adhere to US Food and Drug Administration (FDA) health warning requirements for tobacco promotions, according to a study published online ...

In a disclosure that can't eliminate the possibility that bird flu may have spread from one human to another for the first time, US health officials have reported that a person who lived with a ...

HealthDay News — Implementation of opt-out emergency department syphilis screening leads to a dramatic increase in screening and diagnosis, especially among pregnant individuals, according to a study ...

Compared with current smokers, adjusted risk for AF was lower in former smokers and those who quit during the study.

Six strong recommendations developed, including initial management of dietary modifications and ensuring adequate fluid, fiber intake ...

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

Liraglutide results in greater reduction in BMI than placebo plus lifestyle intervention for children with obesity ...

The Epitomee capsule is a self-administered medical device that once ingested, expands in the stomach and occupies the space creating a sensation of fullness.